Biotechnology Value Fund

Summary

Biotechnology Value Fund is the famous VC, which was founded in 1993. The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Biotechnology Value Fund, startups are often financed by Third Rock Ventures, The Column Group, Celgene. The meaningful sponsors for the fund in investment in the same round are EcoR1 Capital, RA Capital Management, Nextech Invest. In the next rounds fund is usually obtained by EcoR1 Capital, Surveyor Capital, RA Capital Management.

We also calculated 5 valuable employees in our database.

Among the most successful fund investment fields, there are Health Care, Medical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Relay Therapeutics, Merus, Vividion Therapeutics

Comparing to the other companies, this Biotechnology Value Fund performs on 30 percentage points more the average number of lead investments. The high activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. The real fund results show that this VC is 11 percentage points more often commits exit comparing to other companies. The top amount of exits for fund were in 2019. Deals in the range of 50 - 100 millions dollars are the general things for fund.